I-Ticiegrelor Newgreen Ukubonelela nge-APIS 99% i-ticrelor powder umfanekiso

I-Ticiegrelor Newgreen Boxgree I-APIS 99% POCMDR

Inkcazo emfutshane:

Igama lophawu: iNewgreen

Inkcazo yemveliso: 99%

Ubomi beShelfi: 24Month

Indlela yokugcina: Indawo eyomileyo eyomileyo

Imbonakalo: ipowder emhlophe

Isicelo: Ishishini lamachiza

Ukupakisha: 25kg / idrum; I-1kg / ibhegi ye-foil okanye iingxowa ezenziwe ngokwezifiso

Thumela i-imeyile kuthi

Iinkcukacha zemveliso

Inkonzo ye-OEM / ODM

Iimpawu zeMveliso

Ingcaciso yeMveliso

I-Ticiegrelor sisiyobisi se-antipalett, i-P2Y12 i-Adagonist, esetyenziswa ikakhulu ukuthintela imicimbi yentliziyo, ngakumbi kwizigulana ezine-syndrome (ACs). Inciphisa umngcipheko weTrambosis ngokuthintela ukwahlula-hlulwa kweplanethi.

Oomatshini abaphambili
Ithintelo lokudibanisa
I-Titagolor ibophelela umva kwi-P2Y12 ye-P2Y12 kumhlaba weplatelet, ukuthintela ukusebenza kweplatelet kunye nokudityaniswa okubangelwa yi-adenosine diphosphate (i-ADP), ukunciphisa ukwenziwa kwe-aden.

Iphawu
I-Ticiegrelor isetyenziswa ikakhulu kwezi meko zilandelayo:
I-Syronary ye-Accoriary Syndrome:Kubandakanywa nezigulana ezine-angina engafunekiyo kunye ne-myocardial infaction, ihlala isetyenziswa ngokudibeneyo ne-aspirin ukunciphisa umngcipheko we-Cardiovacular.
UKUTHINYELWA KWEENDAWO ZE-CROOVASCRUS:Kwizigulana ezisele zinomsitho wentliziyo ukuthintela enye.

Coa

Izinto	Inkcazo	Iziphumo
Imbonakalo	Umgubo omhlophe	Dibanisa
Iodolo	Phawula	Dibanisa
I-assay	≥99.0%	I-99.8%
Ngcangcazela	Phawula	Dibanisa
Ilahleko yokomisa	I-4-7 (%)	I-4.12%
Iyonke i-ash	I-8% max	I-4.85%
Intsimbi enzima	≤10 (i-PPM)	Dibanisa
I-Arsenic (AS)	I-0.5ppm max	Dibanisa
Khokelela (PB)	I-1PPM max	Dibanisa
I-Mercury (HG)	I-0.1ppm max	Dibanisa
I-pile itreyini	I-10000cfu / g max.	I-100cfu / g
I-Youst & Ibumba	I-100cfu / g max.	>I-20cfu / g
Isalmonella	Engalunganga	Dibanisa
E.coli.	Engalunganga	Dibanisa
I-staphylocococcus	Engalunganga	Dibanisa
Ukuqukumbela	Bafanelekile
Ukugcinwa	Ivenkile kwindawo evaliweyo eneqondo elingaphantsi kunye nobushushu obuphantsi kwaye akukho lula ilanga.
Beka ubomi kwishelufa	Iminyaka emi-2 xa igcinwe ngokufanelekileyo

Imiphumela

I-Ticiegrelor inyamezeleke kakuhle, kodwa ezinye iziphumo ebezingalindelekanga zinokwenzeka, kubandakanya:

Ukopha:Esona siphumo siqhelekileyo, esinokubangela imicimbi ethobekileyo okanye esemnyameni.

Ubunzima bokuphefumla:Abanye abaguli banokufumana ubunzima bokuphefumla okanye ukukhohlela.

I-Gastrointentinalnjengama-nausea, isisu esibuhlungu okanye ukungcungcutheka.

Amanqaku

Umngcipheko wobuphuma:Umngcipheko wokwapha kufuneka ubekwe esweni rhoqo xa usebenzisa iTiciagrelor, ngakumbi xa isetyenziswa ngokudibeneyo kunye nenye amachiza e-anticoulant.

Umsebenzi we-hepatic:Sebenzisa ngononophelo kwizigulana ezinesifo sokungakhathali; Uhlengahlengiso lwe-Dose lunokuba yimfuneko.

Unxibelelwano lweziyobisi:I-Ticiegrelor inokunxibelelana nezinye iziyobisi. Kuya kufuneka uxelele ugqirha wakho malunga nazo zonke iziyobisi othathayo ngaphambi kokuyisebenzisa.